We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Bioperfectus Stock

Invest in or calculate the value of your shares in Bioperfectus or other pre-IPO companies through EquityZen's platform.

Get Started

Bioperfectus Stock

One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market

About Bioperfectus Stock

Founded

2010

Industries

Travel and Tourism, Manufacturing, Space

BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010. BioPerfectus, located in Taizhou; having talented professional R&D, marketing and service network through headquarter and branch offices in Shanghai, Beijing and Xian. Specialized in real time PCR kits, nucleic acid extractions, rapid tests, automation laboratory devices. Missioned by social responsibility of humanity needs, we develop advance technologies to provide reliable, accurate and high-quality products and fast response to any infectious diseases globally. BioPerfectus has manufacturing centers, certified by international known quality standards, covering over 30000 sqm and efficiently distributing products all around the world.

Bioperfectus Press Mentions

Stay in the know about the latest news on Bioperfectus

Auxiliary test paper detection device

patents • May 03, 2025

Test paper testing auxiliary device

patents • Mar 29, 2025

Test result reading device

patents • Nov 30, 2024

Locked Features

Join now and verify your accreditation status to gain access to:

  • Bioperfectus Current Valuation
  • Bioperfectus Stock Price
  • Bioperfectus Management
  • Available deals in Bioperfectus and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Bioperfectus Cap Table and Funding History by Share Class and Liquidity Preferences
    • Bioperfectus Revenue and Financials
    • Bioperfectus Highlights
    • Bioperfectus Business Model
    • Bioperfectus Risk Factors
  • Bioperfectus Research Report from SACRA Research
Join Now

Trading Bioperfectus Stock

How to invest in Bioperfectus stock?

Accredited investors can buy pre-IPO stock in companies like Bioperfectus through EquityZen funds. These investments are made available by existing Bioperfectus shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Bioperfectus stock?

Shareholders can sell their Bioperfectus stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Bioperfectus